Our data implicating the inverse relationship between NOTCH1 activation and the BMP-like state represents a potential therapeutic strategy in T-ALL and provide rationale for NOTCH1 activation, rather than inhibition, to treat high-risk T-ALL. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.